Showing 1 - 10 of 1,183
but also those who have not been vaccinated. In order to achieve this, a high vaccination rate is necessary; for many … vaccinations was upgraded in 2007 within the scope of the reform of the health system. The reimbursement of patients' vaccination … evaluate to what extent the health insurance companies promote the increasing of vaccination coverage rate today and what …
Persistent link: https://www.econbiz.de/10009503925
Traditional economic models of vaccination behavior simply assume that agents free-ride on the vaccination decisions of … conjectural variation model, to explain how a positive peer effect regarding vaccination behavior arises. We conduct two empirical … studies using Japanese data in these models. The first empirical analysis, using a data set on the vaccination behavior of …
Persistent link: https://www.econbiz.de/10011805101
Persistent link: https://www.econbiz.de/10014304997
responsible for important morbidity in men and women. Since 2007, HPV vaccination has been recommended and funded for all girls … quadrivalent HPV vaccination programme for 12-year-old girls in Germany would be cost effective. Here we present the results from a … dynamic transmission model that can be used to evaluate the impact and cost-effectiveness of different vaccination schemas …
Persistent link: https://www.econbiz.de/10009752876
Persistent link: https://www.econbiz.de/10011482970
Persistent link: https://www.econbiz.de/10011542524
Persistent link: https://www.econbiz.de/10010492492
We investigate the effects of the introduction of a population-wide Human Papillomavirus (HPV) vaccination program on …
Persistent link: https://www.econbiz.de/10013163652
We evaluate the impact of oral polio vaccines on the incidence of disabilities in India, focusing on polio-related disability. Polio was hyperendemic in India even as recently as the early 1990s but the country was declared wild polio virus-free in 2014. Average treatment effects on the treated...
Persistent link: https://www.econbiz.de/10012888356
We estimate a model of damage to corporate earnings from COVID-19. A pandemic decreases earnings due to costly mitigation and lower growth rates. The arrival of a vaccine, modeled as a Poisson process, reverts earnings to normal. We fit our model to timely measures of expected damage given by...
Persistent link: https://www.econbiz.de/10012823517